Cargando…
Knockdown of HOXA10 reverses the multidrug resistance of human chronic mylogenous leukemia K562/ADM cells by downregulating P-gp and MRP-1
Autores principales: | Yi, Ying-Jie, Jia, Xiu-Hong, Wang, Jian-Yong, Li, You-Jie, Wang, Hong, Xie, Shu-Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599347/ https://www.ncbi.nlm.nih.gov/pubmed/37830154 http://dx.doi.org/10.3892/ijmm.2023.5315 |
Ejemplares similares
-
CAC1 knockdown reverses drug resistance through the downregulation of P-gp and MRP-1 expression in colorectal cancer
por: Chen, Nanzheng, et al.
Publicado: (2019) -
Matrine reverses the drug resistance of K562/ADM cells to ADM and VCR via promoting autophagy
por: Li, Zhao, et al.
Publicado: (2020) -
Corrigendum to “Usnea Acid as Multidrug Resistance (MDR) Reversing Agent against Human Chronic Myelogenous Leukemia K562/ADR Cells via an ROS Dependent Apoptosis”
por: Wang, Wenjing, et al.
Publicado: (2021) -
Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR
por: Wang, Yu Jia, et al.
Publicado: (2017) -
[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling
por: Liu, Yan-Hong, et al.
Publicado: (2023)